Iovance Biotherapeutics (IOVA) Competitors $5.78 +0.17 (+3.03%) Closing price 04:00 PM EasternExtended Trading$5.79 +0.01 (+0.17%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IOVA vs. LEGN, BBIO, AXSM, BPMC, TLX, ELAN, LNTH, NUVL, CYTK, and VRNAShould you be buying Iovance Biotherapeutics stock or one of its competitors? The main competitors of Iovance Biotherapeutics include Legend Biotech (LEGN), BridgeBio Pharma (BBIO), Axsome Therapeutics (AXSM), Blueprint Medicines (BPMC), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Elanco Animal Health (ELAN), Lantheus (LNTH), Nuvalent (NUVL), Cytokinetics (CYTK), and Verona Pharma (VRNA). These companies are all part of the "pharmaceutical products" industry. Iovance Biotherapeutics vs. Legend Biotech BridgeBio Pharma Axsome Therapeutics Blueprint Medicines Telix Pharmaceuticals Limited American Depositary Shares Elanco Animal Health Lantheus Nuvalent Cytokinetics Verona Pharma Legend Biotech (NASDAQ:LEGN) and Iovance Biotherapeutics (NASDAQ:IOVA) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, community ranking, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability. Does the MarketBeat Community prefer LEGN or IOVA? Iovance Biotherapeutics received 480 more outperform votes than Legend Biotech when rated by MarketBeat users. Likewise, 74.34% of users gave Iovance Biotherapeutics an outperform vote while only 72.03% of users gave Legend Biotech an outperform vote. CompanyUnderperformOutperformLegend BiotechOutperform Votes8572.03% Underperform Votes3327.97% Iovance BiotherapeuticsOutperform Votes56574.34% Underperform Votes19525.66% Which has better valuation & earnings, LEGN or IOVA? Iovance Biotherapeutics has lower revenue, but higher earnings than Legend Biotech. Legend Biotech is trading at a lower price-to-earnings ratio than Iovance Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLegend Biotech$285.14M24.93-$518.25M-$0.95-40.97Iovance Biotherapeutics$1.19M1,436.82-$444.04M-$1.49-3.77 Is LEGN or IOVA more profitable? Legend Biotech has a net margin of -66.92% compared to Iovance Biotherapeutics' net margin of -451.25%. Legend Biotech's return on equity of -29.69% beat Iovance Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Legend Biotech-66.92% -29.69% -19.45% Iovance Biotherapeutics -451.25%-58.43%-45.48% Does the media refer more to LEGN or IOVA? In the previous week, Iovance Biotherapeutics had 3 more articles in the media than Legend Biotech. MarketBeat recorded 7 mentions for Iovance Biotherapeutics and 4 mentions for Legend Biotech. Legend Biotech's average media sentiment score of 1.72 beat Iovance Biotherapeutics' score of 0.70 indicating that Legend Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Legend Biotech 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Iovance Biotherapeutics 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of LEGN or IOVA? 70.9% of Legend Biotech shares are held by institutional investors. Comparatively, 77.0% of Iovance Biotherapeutics shares are held by institutional investors. 0.0% of Legend Biotech shares are held by company insiders. Comparatively, 12.1% of Iovance Biotherapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk & volatility, LEGN or IOVA? Legend Biotech has a beta of 0.18, meaning that its stock price is 82% less volatile than the S&P 500. Comparatively, Iovance Biotherapeutics has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Do analysts rate LEGN or IOVA? Legend Biotech presently has a consensus target price of $79.50, indicating a potential upside of 104.27%. Iovance Biotherapeutics has a consensus target price of $21.07, indicating a potential upside of 275.60%. Given Iovance Biotherapeutics' higher probable upside, analysts plainly believe Iovance Biotherapeutics is more favorable than Legend Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Legend Biotech 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 3.00Iovance Biotherapeutics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 SummaryIovance Biotherapeutics beats Legend Biotech on 9 of the 17 factors compared between the two stocks. Get Iovance Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IOVA vs. The Competition Export to ExcelMetricIovance BiotherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.72B$3.09B$5.84B$9.20BDividend YieldN/A1.57%4.78%3.85%P/E RatioN/A10.3316.3314.11Price / Sales1,436.82342.88460.3879.70Price / CashN/A183.6144.0437.47Price / Book2.463.637.744.77Net Income-$444.04M-$71.72M$3.18B$245.88M7 Day Performance0.72%-0.24%-0.53%-0.90%1 Month Performance-4.59%2.30%1.81%-0.52%1 Year Performance-64.43%-9.30%18.90%16.50% Iovance Biotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IOVAIovance Biotherapeutics4.0575 of 5 stars$5.78+3.0%$21.07+264.6%-53.4%$1.76B$1.19M-3.88500LEGNLegend Biotech2.6195 of 5 stars$36.42+0.1%$79.50+118.3%-35.2%$6.65B$285.14M-38.341,800Positive NewsGap UpBBIOBridgeBio Pharma4.7364 of 5 stars$34.90+10.6%$49.08+40.6%+2.4%$6.60B$9.30M-14.48400Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap UpAXSMAxsome Therapeutics4.5395 of 5 stars$131.15-0.4%$147.13+12.2%+59.2%$6.36B$270.60M-20.08380Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageBPMCBlueprint Medicines3.0196 of 5 stars$93.94-1.3%$123.83+31.8%+3.4%$5.97B$249.38M-44.52640Earnings ReportTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$17.19-0.6%$22.00+28.0%N/A$5.79B$637.08M0.00N/ANews CoverageGap UpELANElanco Animal Health4.1542 of 5 stars$11.26-3.4%$16.29+44.7%-31.0%$5.57B$4.42B28.159,300Analyst ForecastLNTHLantheus4.588 of 5 stars$79.94-2.5%$131.86+64.9%+42.3%$5.56B$1.30B13.30700Analyst RevisionNUVLNuvalent1.8522 of 5 stars$77.93-3.7%$112.36+44.2%+0.5%$5.54BN/A-22.4640Upcoming EarningsInsider TradeCYTKCytokinetics4.2215 of 5 stars$46.16+10.9%$82.00+77.6%-33.5%$5.45B$7.53M-8.58250High Trading VolumeVRNAVerona Pharma1.9573 of 5 stars$64.21+4.1%$57.14-11.0%+277.6%$5.13B$460,000.00-33.4430 Related Companies and Tools Related Companies Legend Biotech Competitors BridgeBio Pharma Competitors Axsome Therapeutics Competitors Blueprint Medicines Competitors Telix Pharmaceuticals Limited American Depositary Shares Competitors Elanco Animal Health Competitors Lantheus Competitors Nuvalent Competitors Cytokinetics Competitors Verona Pharma Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IOVA) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
